Tag: genomics
-
FDA Approves Biomarker-Targeting Cancer Drug
The Food and Drug Administration yesterday approved a treatment for solid tumor cancers that focuses on specific cancer-causing genetic conditions rather than location of the cancer in the body.
-
RNA Therapy Helps Reduce Preeclampsia Symptoms
Experimental treatments with engineered RNA are shown in lab animals to reduce symptoms of preeclampsia, a disorder causing high blood pressure in pregnant women.
-
Faster Crop Breeding Techniques Made Available to Other Scientists
Plant scientists in the U.K. and Australia are making available to their colleagues experimental techniques that speed-up breeding cycles for more commercial crop varieties.
-
DNA-Encoded Synthetic Antibodies Protect Against Ebola
Synthetic antibodies derived from survivors of Ebola infections are shown to be quick and simple to develop, and in lab mice to provide long-term protection against against Ebola viruses.
-
RNA Therapeutics Company Raises $30M in First Venture Round
A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells.
-
Rapid Antimicrobial Resistance Diagnostics System Advances
Developers of a system that uses high-speed genomic analysis with standard semiconductor chips say they demonstrated an ability to sequence bacterial DNA directly from raw blood samples.
-
FDA Clears Some Drug Reaction Genetic Tests, Warns About Others
The Food and Drug Administration cleared a consumer genetics company’s tests for gene variations associated with effective or adverse drug reactions, but warned about similar tests from non-authorized providers.
-
Synthetic DNA Company Raising $70 Million in IPO
A 5 year-old enterprise developing synthetic DNA for medical and agricultural chemicals, as well as data storage, is raising $70 million in its initial public stock offering.
-
FDA Preparing Animal, Plant Biotech Regulatory Guidance
The Food and Drug Administration intends to issue new regulatory guidance to cover advances in biotechnology, including genome editing, in animals and plants.
-
Gene Silencing Technology Licensed in $3.7B Deal
Dicerna Pharmaceuticals, developing treatments for disease that silence genes by interfering with their RNA instructions, is licensing its technology to drug maker Eli Lilly and Co